18
Feb

Genoskin presents its technology in the UK

Genoskin presents its technology in the UK On Thursday, 20th, the Genoskin team will be presenting its technology during a seminar in Slough, UK.  Next Thursday, Business Development Manager, Michael Pastore, and Chief Commercial Officer, Eric Merle will be giving a seminar in Slough, UK. This seminar will be the opportunity to present our ex-vivo skin assay platform and inform
Read more
14
Feb

We’d love to meet you at the SOT Annual Meeting and ToxExpo (SOT2020)

We’d love to meet you at the SOT Annual Meeting and ToxExpo (SOT2020) The 2020 edition of the SOT Annual Meeting and ToxExpo (SOT2020) is only one month away and Genoskin is excited to exhibit at booth #1200! Let's meet at ToxExpo! Our new Field Application Director, Yolaine Robitaille and Eric Merle, (Genoskin's Chief Commercial Officer) will be there to share our
Read more
10
Feb

Genoskin reinforces R&D capabilities

Genoskin reinforces R&D capabilities Genoskin Research & Development offers new services to portfolio available to partners with the addition of new equipment. Genoskin's R&D recently added a Meso Scale QuickPlex SQ120 for high-performance electroluminescence immunoassays. This new instrument will enable our teams to detect the presence of biomarkers down to femtoscale concentrations. Genoskin also added a best-in-class solar simulator (Solar Light) capable of
Read more
23
Jan

Genoskin wishes you a Happy Year of the Rat!

Genoskin wishes you the best for 2020, the Year of the Rat! Thank you so much for your trust and support, 2019 was another amazing year! We can't wait to continue our partnership this year. And since 2020 is also the Year of the Rat, let's work together to keep the rats out of the labs and generate better data
Read more
15
Jan

Genoskin’s CEO to speak at Café des Sciences Boston

Genoskin's CEO, Pascal Descargues to speak at the first FACCNE 'Café des Sciences' of 2020! Meet our CEO Pascal at the WeWork building on January 23  and discover everything about our real live human skin assays.  2020 welcomes a new year of Café des Sciences, and Pascal is the first speaker invited! Pascal will give a presentation on how to
Read more
10
Jan

Incospharm publishes results using NativeSkin®

Incospharm publishes results using NativeSkin® Korean company Incospharm publishes data generated using our hi-tech human skin assay, NativeSkin®, in the International Journal of Molecular Sciences. Incospharm developed an innovative complex of peptides meant to stimulate the skin basement membrane proteins expression for anti-aging effects. The ex vivo evaluation using NativeSkin® confirmed that the topical application of this peptide complex significantly
Read more